A statement was made by the Turkish Neurological Society on the occasion of the 22 July World Brain Day, the main theme of which was determined as “MS”.
The President of the Association, whose evaluations were included in the statement, Prof. Dr. Şerefnur Öztürk reminded that on this day announced by the World Federation of Neurology, activities are planned with member countries to raise awareness around the world about a different neurological disease or a condition that affects brain health, and to provide information about precautions, symptoms and treatment.
Pointing out that the healthy functioning of the brain directly affects human health, Öztürk reported that neurological diseases cause the most loss of function and death in the second place worldwide.
prof. Dr. Öztürk said, “Stroke, which is the most common neurological disease in Turkey, ranks second among the causes of death in our country. Every year, 17 million people have a stroke in the world, 6 million of these people die. In our country, approximately 400 thousand Alzheimer’s, 750 thousand epilepsy, 100 thousand people suffer from stroke. There are a thousand Parkinson’s patients and around 80,000 MS patients.” shared his knowledge.
“MS disease affects an estimated 70-80 thousand people in Turkey”
prof. Dr. Hüsnü Efendi shared the following information about MS in the statement:
“MS disease affects approximately 4-5 million people in the world and an estimated 70-80 thousand people in Turkey. The disease usually occurs in young adults, between the ages of 20 and 40. The incidence in women is 2-2.5 times higher than in men The disease is seen with a high frequency in Northern Europe, the North of America and Canada, but at a low rate in the equatorial region. In Turkey, the incidence is lower than Northern Europe, but it is acceptable at a moderate level. The highest risk factor for MS is genetic predisposition. and environmental factors, all of which are not yet fully known.”
prof. Dr. Hüsnü Efendi stated that many drugs with different mechanisms of action have been used in the treatment of MS disease in recent years, and phase II and phase III studies with different molecules are continuing.
Efendi emphasized that many universities and training and research hospitals in Turkey have MS outpatient clinics and enough experienced physician staff.
“Both vaccines applied in our country can be recommended for individuals with MS”
Stating that individuals with MS do not differ from other individuals in terms of the risk of contracting Kovid-19 and the severity of the disease, Efendi said:
“It is appropriate for people with MS who have not received any treatment to have the Kovid-19 vaccine, like everyone else. There may be a possibility that the effectiveness of the vaccine may be partially lower in some people with MS under treatment. However, these treatments do not constitute an obstacle to the vaccination. “Both vaccines can be recommended for individuals with MS. These vaccines are not expected to trigger an MS attack. If people with MS have any other disease other than MS they are under treatment for, it would be appropriate for them to consult their physicians regarding the vaccination.”
prof. Dr. Stating that nutrition, sports and walking, non-smoking and vitamin D intake are important for individuals with MS, Efendi said, “The most important thing to say for MS patients is that it is not a helpless disease, an incurable disease. Newly developed treatment options and Considering the new drugs that are still in the trial phase, more effective and safe MS treatment is now possible with the increasing treatment options. used the phrases.